Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rasagiline ODT for motor fluctuations in primary Parkinson's disease
CTR20140734Phase 3Completed
- Sponsor
- Eternal Light Pharmaceutical
- Start
- Apr 2015
- Modality
- Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of rasagiline in Parkinson's disease (PD), sponsored by Eternal Light Pharmaceutical. Started Apr 2015; status: completed.
02
Drugs
rasagiline
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on CTR20140734.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140734.